Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest National Heart, Lung, and Blood Institute Stories

2009-12-11 04:00:00

CAMBRIDGE, Mass., Dec. 11 /PRNewswire/ -- Gwathmey, Inc., a pre-clinical contract research organization and biotechnology company specializing in cancer, staph aureus, and cardiovascular disease announces a new CEO. Gwathmey Pre-clinical Services announced today that Rosalie Dunn, Ph.D., has joined Gwathmey as Chief Executive Officer. Dr. Dunn has over 28 years of experience working with small businesses and the federal government. Prior to joining Gwathmey, Dr. Dunn managed...

2009-12-06 09:17:33

A new study by researchers from the Medical College of Wisconsin, in Milwaukee, found a substantial variation in hydroxyurea utilization for pain and other sickle cell disease complications in children. Barriers to its use on the part of both providers and patients were also identified. The study led by Amanda M. Brandow, DO, MS, assistant professor of pediatrics at the Medical College and Children's Research Institute at the Children's Hospital of Wisconsin, will be presented at the American...

2009-12-02 06:00:00

SOUTH PLAINFIELD, N.J., Dec. 2 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million Challenge Grant award from the National Heart, Lung, and Blood Institute (NHLBI) as part of the National Institutes of Health (NIH). According to the NIH, 840 grants were awarded out of the approximately 20,000 applications they received for the Challenge Grants, a new program under the American Recovery and Reinvestment Act designed to stimulate new areas of research....

2009-11-06 13:51:38

Different CPR durations found equally successful; CPR device does not add benefit Enrollment has ended early in a large, multicenter clinical trial comparing two distinct resuscitation strategies delivered by emergency medical service (EMS) providers to increase blood flow during cardiac arrest. The study's independent monitoring board and the National Heart, Lung, and Blood Institute (NHLBI), the lead sponsor of the study, stopped enrollment based on preliminary data suggesting that neither...

2009-11-05 09:14:00

WASHINGTON, Nov. 5 /PRNewswire/ -- Sarah Temple, Senior Vice President of Social Marketing Practice, Ogilvy Public Relations Worldwide, was named the 2009 "Washington PR Woman of the Year" by Washington Women in Public Relations (WWPR) at its awards ceremony. Each year, WWPR presents an award to a senior level Washington area female PR practitioner as a means to honor and celebrate the accomplishments of PR women and expand awareness of contributions to the industry. This year's luncheon...

2009-11-02 09:44:03

Smokers and those at risk far less likely to talk to their doctor about symptoms Awareness of COPD"”chronic obstructive pulmonary disease"”continues to grow in the United States, according to national survey results released today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Sixty-eight percent of adults are now aware of COPD, a disease that affects 1 in 5 people over age 45, compared with 64 percent last year, and 49 percent in a...

2009-10-07 09:00:00

National Jewish Health, University of Colorado Denver, University of Pittsburgh, Dana-Farber Cancer Institute and Boston University in joint NHLBI project DENVER, Oct. 7 /PRNewswire-USNewswire/ -- Researchers at five research centers have been awarded an $11 million, two-year grant from the National Heart Lung and Blood Institute as part of the NIH Recovery Act that will allow a team of national scientists to delve deeply into the biology of two fatal lung diseases for which there are...

2009-09-29 10:06:25

In this week's PLoS Medicine, Liza Dawson (National Institutes of Health) and colleagues discuss the scientific and ethical issues associated with choosing clinical trial designs when there is no consensus on what constitutes usual care. For example, in 2002 a clinical trial designed to evaluate the best way of ventilating patients with a severe lung condition called acute respiratory distress syndrome sparked a major controversy. Critics charged that management of the condition in the...

2009-09-14 07:00:00

BOSTON, Sept. 14 /PRNewswire/ -- The Heart Failure Society of America's (HFSA) 13th Annual Scientific Meeting convened Sunday, September 13, 2009 at the Hynes Convention Center in Boston. This three-day meeting -- a forum for heart failure specialists to present research findings and advances in treatment -- will address emerging trends in research and new developments in the approach to treating patients with this condition. The scientific program will kick off with an opening plenary...

8984555f751c69a825f7a67f07c682081
2009-07-28 16:40:00

The National Institutes of Health (NIH) said on Tuesday it had halted a trial of the drug sildenafil for patients with sickle cell disease, saying the drug caused serious medical problems.The trial was testing the safety and effectiveness of sildenafil, sold by Pfizer as Viagra and Revatio, as a treatment for pulmonary hypertension in patients with sickle cell disease, said the National Heart, Lung, and Blood Institute (NHLBI).Patients without sickle cell disease taking the sildenafil --...